EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder

Yu-Ting Li, Chi Zhang, Jia-Cheng Han, Yu-Xuan Shang, Zhu-Hong Chen, Guang-Bin Cui, Wen Wang iD

Therapeutic Advances in Psychopharmacology · 2024-01 · 14

DOI: 10.1177/20451253241243290 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Therapeutic Advances in Psychopharmacology, online erschienen am 04.05.2024. Verfasst von Yu-Ting Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Functional and Molecular Imaging Key Lab of Shaanxi Province, Tangdu Hospital, Fourth Military Medical University, Xi'an, Sh…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: the Talent Foundation of Tangdu Hospital, the Hovering Program of Fourth Military Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cognitive dysfunctions are one of the key symptoms of schizophrenia (SZ) and major depressive disorder (MDD), which exist not only during the onset of diseases but also before the onset, even after the remission of psychiatric symptoms. With the development of neuroimaging techniques, these non-invasive approaches provide valuable insights into the underlying pathogenesis of psychiatric disorders and information of cognitive remediation interventions. This review synthesizes existing neuroimaging studies to examine domains of cognitive impairment, particularly processing speed, memory, attention, and executive function in SZ and MDD patients. First, white matter (WM) abnormalities are observed in processing speed deficits in both SZ and MDD, with distinct neuroimaging findings highlighting WM connectivity abnormalities in SZ and WM hyperintensity caused by small vessel disease in MDD. Additionally, the abnormal functions of prefrontal cortex and medial temporal lobe are found in both SZ and MDD patients during various memory tasks, while aberrant amygdala activity potentially contributes to a preference to negative memories in MDD. Furthermore, impaired large-scale networks including frontoparietal network, dorsal attention network, and ventral attention network are related to attention deficits, both in SZ and MDD patients. Finally, abnormal activity and volume of the dorsolateral prefrontal cortex (DLPFC) and abnormal functional connections between the DLPFC and the cerebellum are associated with executive dysfunction in both SZ and MDD. Despite these insights, longitudinal neuroimaging studies are lacking, impeding a comprehensive understanding of cognitive changes and the development of early intervention strategies for SZ and MDD. Addressing this gap is critical for advancing our knowledge and improving patient prognosis.

Schlagwörter

Stichwörter der Autor:innen

AttentionExecutive functionMajor depressive disorderMemoryNeuroimagingProcessing speedSchizophrenia

Autor:innen und Institutionen

  • Department of Radiology, Functional and Molecular Imaging Key Lab of Shaanxi Province, Tangdu Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
  • Department of Radiology, Functional and Molecular Imaging Key Lab of Shaanxi Province, Tangdu Hospital, Fourth Military Medical University, 569 Xinsi Road, Xi'an 710038, Shaanxi, China.

ORCID-Profile: Wen Wang

Förderung

  • the Talent Foundation of Tangdu Hospital
  • the Hovering Program of Fourth Military Medical University

Zitieren

APA

Li, Y. T., Zhang, C., Han, J. C., Shang, Y. X., Chen, Z. H., Cui, G. B., & Wang, W. (2024). Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder. Therapeutic Advances in Psychopharmacology, 14. https://doi.org/10.1177/20451253241243290

Vancouver

Li YT, Zhang C, Han JC, Shang YX, Chen ZH, Cui GB, et al. Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder. Therapeutic Advances in Psychopharmacology. 2024;14. doi:10.1177/20451253241243290

BibTeX
@article{Li2024,
  author = {Li, Yu-Ting and Zhang, Chi and Han, Jia-Cheng and Shang, Yu-Xuan and Chen, Zhu-Hong and Cui, Guang-Bin and Wang, Wen},
  title = {Neuroimaging features of cognitive impairments in schizophrenia and major depressive disorder},
  journal = {Therapeutic Advances in Psychopharmacology},
  year = {2024},
  volume = {14},
  doi = {10.1177/20451253241243290}
}
Kostenlos starten →